Total genotyping rate across all individuals (66 cases, 830 controls) was 0.98, and after all pruning the initial probe number (from which all described priority and GWAS probes were drawn) was 311,399.
Three previous studies have described priority setting for cancer drugs, focusing on the decision making process and reasoning used by priority setting bodies [ 6- 8].
Menon et al. described priority setting in four steps: (1) identification of health care needs, (2) allocation of resources, (3) communication of decisions to stakeholders, and (4) management of feedback from them [ 13].
In order to build on existing literature, which is extensive in describing priorities in health care qualities, we provide only a short summary of the qualities valued by participants and then focus on the latter issues of the enactment of care.
To describe priority setting we used qualitative case study methods.
The priority setting literature describes priority setting in various health care contexts [ 1- 9].
To describe priority setting in a hospital we used a qualitative case study.
Qualitative case study research was used to describe priority setting at the microallocation level.
The current work adds to a limited yet growing body of international literature describing priority setting practices in health organizations.
Interview participants were asked to describe priority setting decisions in relation to SARS and their thoughts about it.
